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▪ Placental structure and models
▪ Placental permeation 
▪ Placental metabolism and regulation (induction/inhibition)
▪ Sulfotransferase enzymes in trophoblast
▪ Bisphenol A




•Trophoblasts and syncytiotrophoblasts line the maternal villar surface in a monolayer-
like fashion.
•Constitute the rate limiting barrier to exchange between the maternal and fetal blood. 
The placental barrier
Syme et al., Drug transfer and metabolism by the human placenta, Clin Pharmacokinet 2004: 43(8): 487-514
Models of the human placenta
▪ In vivo models – Anatomical and functional differences between mammalian placentas 
makes it difficult to extrapolate animal studies to humans.
▪ In vitro models
▪ Perfused placental cotyledon
▪ Isolated trophoblast plasma membrane
▪ Isolated transporters and receptors
▪ Villous explants
▪ Primary cultures (cytotrophoblasts)
▪ Immortalized cell lines (BeWo, JAr, JEG, HRP-1, etc.)
Refn. Bode et al. In Vitro models for studying trophoblast transcellular transport, Methods Mol Med. 2006;122:225-39 
Sastry, B.V., Adv Drug Deliv Rev., 1999 Jun 14. 38(1): p. 17-39.

















▪    Though enzyme expression is much more restricted than hepatic metabolism, those 
that are functional metabolize xenobiotics as well as hormones.
▪ Placental enzymes CYP1A1/1A2, CYP19 (aromatase), GST, UGT, SULT
▪ Maternal blood-borne chemicals (drugs/polychlorinated biphenyls/pesticides) alter 
expression and activity.
• Altered steroid metabolism. 
• Altered xenobiotic/drug metabolism.
▪ Syme et al., Drug transfer and metabolism by the human placenta, Clin Pharmacokinet 2004: 43(8): 487-514
▪ Avery, M.L., The presence of inducible Cytochrome P450 types 1A1 and 1A2 in the BeWo cell line, Placenta, 2003, 24, 45-52
▪ Pasanen, The expression and regulation of drug metabolism in the human placenta, ADDR, 38, 1999, 81-97
▪ Sulfation of drugs (salbutamol, ritodrine, and fenoterol) has been detected in placenta.
▪ Sulfation is mediated by a family of enzymes – the sulfotransferases. 
▪ Several sulfotransferase isoforms have been detected in term placenta at the mRNA level; 
some of these are also functionally active.
▪ Sulfotransferases and UDP glucuronosyltransferases (UGT) act on similar substrates 
(containing -OH and NH2 groups).  
▪ Placental UGT activity is low and very variable.
Objective :
1. To characterize the functional activity of selected sulfotransferase 
isoforms in in vitro trophoblast systems ( the trophoblast cell line BeWo 
and primary cytotrophoblasts).
2. Study their regulation (induction/inhibition) by foreign chemicals that 
accumulate in placenta in significant concentrations. 
Sulfotransferases 
▪ Cytosolic – Metabolism of xenobiotics and small endogenous ligands 
such as steroids, bile acids, and neurotransmitters.
▪ Membrane-bound – Sulfation of peptides, proteins, lipids; intracellular signaling.
Fig: Hemmerich, S., D. Verdugo, and V.L. Rath, Strategies for drug discovery by targeting sulfation pathways. Drug Discov 




No substantial activity 
towards endogenous or 
xenobiotic substrates
SULT2A1
▪ Substrates - Hydroxysteroids
▪ No functional activity in 
trophoblast
SULT2B1
▪ Substrates - Cholesterol
▪ Active in placenta as 




▪ Main sulfotransferase responsible 
for xenobiotic elimination. 
▪ Active in placenta
▪ Mainly responsible for 
sulfation of estrogens
▪ Low placental activity
1E
SULT1A1 
▪ Principal human sulfotransferase involved in the elimination of xenobiotics. 
▪ Tissue – Liver, brain, breast, intestine, endometrium, adrenal gland, platelets, placenta, 
kidney, lung
▪ Sulfates small phenolic substrates, drugs (minoxidil, troglitazone), hormones such as 17-β-
estradiol and thyroid hormones
▪ Genetic polymorphisms in SULT1A1 (R213H), which cause altered functional activity, have 
been associated with increased risk of cancer.
SULT1A3
▪ Sulfates amines and the high expression level of this enzyme in the intestine has been 
associated with detoxifying dietary biogenic amines.
SULT1E1
▪ Tissue – Liver, jejenum, endometrium
▪ Substrates – Endogenous and synthetic estrogens, iodothyronines
▪ Deletion of the gene in mice causes placental thrombosis and spontaneous fetal loss. 
Sulfotransferase mRNA expression in BeWo and in primary trophoblast
β-Actin SULT1A3 SULT1A1 SULT1E1
Lanes 1, 6,8,10 – Primary cytotrophoblast mRNA probed with primers for β-actin, SULT1A3, SULT1A1, and SULT1E1 respectively 
Lanes 2,  7, 9, 11 – BeWo mRNA probed with primers for β-actin, SULT1A3, SULT1A1, and SULT1E1 respectively 
Sulfotransferases in BeWo
▪ 4-nitrophenol – Km = 0.33+0.12µM – Indicative of SULT1A1-mediated sulfation.
▪ Dopamine – Km = 0.5+0.3µM – Indicative of SULT1A3-mediated sulfation.
Sulfotransferases in BeWo
4-nitrophenol sulfation: 
IC50, DCNP= 0.13+0.1µM; IC50, NaCl= 370+67mM; T50= 42.2+1.3
oC
Dopamine sulfation: 
IC50, DCNP= 1.07+0.095mM; IC50, NaCl= 312+60mM; T50= 39.8+1.12
oC
Sulfotransferases in BeWo
▪ 17β-estradiol sulfation – No saturation. SULT1E1-mediated 17-β-estradiol sulfation exhibits saturation 
in this range.
▪ Furthermore, genistein a potent inhibitor of SULT1E1 did not inhibit 17β-estradiol sulfation
Summary of sulfotransferase expression and activity in trophoblast
▪ In BeWo, both SULT1A1 and SULT1A3 are functionally active but not SULT1E1.
* Agrees with sulfation activities reported in term placenta.
* BeWo is a good model to study the regulation of placental sulfotransferase 
enzymes.
Bisphenol A
▪ Used in the manufacture of polycarbonate plastics, epoxy resins, dental sealants etc. 
▪ Endocrine disrupting chemical - Mimics the action of natural estrogens and regulates the 
expression of estrogen-responsive genes.
▪ Prenatal exposure to BPA -
* Up-regulates immune responses.
* Causes oxidative stress leading to brain impairment. 
* Prostate gland enlargement.
▪ Concentration in amniotic fluid about 5 fold higher than in maternal plasma. Accumulation 
in placenta is also very high.
▪ High placental concentrations can alter placental transfer and metabolism.
* Alters P-glycoprotein mediated efflux in BeWo
1. Yoshino, S., K. Yamaki, et al. (2004). Immunology 112(3): 489-95; 2. Kabuto, H., M. Amakawa, et al. (2004)." Life Sci
74(24): 2931-40; 3.  Jin, H. and K.L. Audus,. Placenta., 2005. 26(Suppl A): p. S96-S103; 4. Schonfelder, G., W. 























Human placental JEG-3 cells incubated 
with increasing concentrations of 
bisphenol A
▪ Aromatase activity induced at 
shorter periods of incubation. 
▪ A dose-dependent inhibition 
was observed at longer 
incubation periods
Nativelle-Serpentini, C., et al.,. Toxicol In Vitro., 2003. 17(4): p. 413-22.
What about the effects of bisphenol A on metabolism?
How do estrogenic compounds affect SULT1A1 and SULT1A3?
▪ SULT1A1 
- Sulfates several endogenous and exogenous estrogens including estradiol.
- Acutely inhibited by estrogenic compounds.
▪ SULT1A3
- Phytoestrogens also acutely inhibit SULT1A3 but with a much lesser potency.
Effects of chronic exposure to estrogenic compounds.
-mRNA levels of SULT1A up-regulated by 4-OH-tamoxifen (16 hrs) and by estradiol (72 
hrs)*. 
*Seth, P., et al., Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of 























▪ SULT1A1 is regulated by estrogenic 
compounds.
▪ Bisphenol A has high placental 
concentrations and is estrogenic.
▪ Bisphenol A alters the metabolic activity of 
other steroid metabolizing enzymes.
▪ Does it do the same for SULT1A1?
Bisphenol A sulfation in trophoblast
▪ In vitro, bisphenol A has been shown to be a substrate for both SULT1A1 and SULT1E1 at a 
concentration of 50µM. 
▪ In trophoblast it exhibits negligible sulfation at concentrations ranging from 50nM - 500µM.
Effect of chronic exposure (48 hrs) of bisphenol A on SULT1A1 activity
▪ Significant decrease in SULT1A1 activity at all tested concentrations of bisphenol A 
Is bisphenol A toxic to trophoblast cells under these conditions?
There was no significant difference in viability at any of the tested 
concentrations of bisphenol A
SULT1A1 β-Actin
Lanes 1 and 6 - Solvent treated
Lanes 2 and 7 – 100nM bisphenol A treated
Lanes 3 and 8 - 1µM bisphenol A treated
Lanes 4 and 9 – 50µM bisphenol A treated
Effect of chronic exposure (48 hrs) of bisphenol A on SULT1A1 mRNA expression 
Bisphenol A treatments did not produce any significant difference in 
SULT1A1 mRNA expression
Effect of chronic exposure (48 hrs) of bisphenol A on SULT1A1 mRNA expression 
Conclusions
▪ The phenolic sulfotransferases SULT1A1 and SULT1A3 are functional in  
trophoblast tissue.
▪ The endocrine disrupting chemical bisphenol A significantly decreased 
SULT1A1 activity at all tested concentrations (100nM-50µM).
▪ This effect was not observed on mRNA expression suggestive of post-
translational regulation.
Future work
▪ Bisphenol A as an acute inhibitor of SULT1A1 
▪ Other estrogenic substances as regulators of placental sulfotransferase 
enzymes.
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